Damora Therapeutics
DMRA
#5766
Rank
A$1.87 B
Marketcap
A$30.35
Share price
3.09%
Change (1 day)
86.99%
Change (1 year)

Earnings for Damora Therapeutics (DMRA)

Earnings in 2026 (TTM): -A$0.39 Billion

According to Damora Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$0.31 Billion a decrease over its 2024 earnings that were of -A$30.65 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Damora Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.39 Billion29.55%
2025 -A$0.31 Billion880.41%
2024 -A$30.65 Million-44.2%
2023 -A$54.92 Million-37.77%
2022 -A$88.25 Million19.08%
2021 -A$74.11 Million48.55%
2020 -A$49.89 Million